Kenfarb & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Kenfarb & Co's LLY Position: Q3 2023 in Review
Kenfarb & Co reduced its Eli Lilly (LLY) stake by 9.6% in Q3 2023, selling an estimated $211K and leaving 3,860 shares worth $2.07M. The position accounts for 1.9% of the portfolio, ranked #12.
Kenfarb & Co first reported a position in LLY in Q4 2021 and has held it in 8 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Kenfarb & Co held 3,860 shares of Eli Lilly worth $2.07M as of Q3 2023.
- Kenfarb & Co sold 410 Eli Lilly shares in Q3 2023, an estimated $211K.
- Eli Lilly made up 1.9% of Kenfarb & Co's portfolio in Q3 2023, its #12 holding.
- Kenfarb & Co first reported a position in Eli Lilly in Q4 2021 and has held it in 8 quarters since.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.